Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease

Molecular Therapy - United States
doi 10.1038/mt.2011.219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rhesus Macaque Rhadinovirus-Associated Disease

Current Opinion in Virology
Virology
2013English

Exome Screening to Identify Loss-Of-Function Mutations in the Rhesus Macaque for Development of Preclinical Models of Human Disease

BMC Genomics
BiotechnologyGenetics
2016English

Bioinformatics Analysis of Ras Homologue Enriched in the Striatum, a Potential Target for Huntington's Disease Therapy

International Journal of Molecular Medicine
MedicineGenetics
2019English

Pyrosequencing as a Method for SNP Identification in the Rhesus Macaque (Macaca Mulatta)

BMC Genomics
BiotechnologyGenetics
2008English

1213 Exosome-Mediated RNAi Delivery for Melanoma Therapy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Arimoclomol as a Potential Therapy for Neuronopathic Gaucher Disease

2018English

Targeting EGFR-mediated Autophagy as a Potential Strategy for Cancer Therapy

International Journal of Cancer
Cancer ResearchOncology
2018English

RNAi-Mediated Gene Suppression in a GCAP1(L151F) Cone-Rod Dystrophy Mouse Model

PLoS ONE
Multidisciplinary
2013English

Architectural Assessment of Rhesus Macaque Pelvic Floor Muscles: Comparison for Use as a Human Model

International Urogynecology Journal
GynecologyUrologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy